Company news

Ascelia Pharma AB news in 2025

Ascelia Pharma AB's news releases, calls and decks from 2025, newest first.

View company

Nomination Committee Appointed for AGM 2026 in Ascelia Pharma AB

December 22, 2025

Change in Number of Shares and Votes in Ascelia Pharma AB

November 28, 2025

Ascelia Pharma Resolves on Conversion of Series C Shares into Ordinary Shares for Delivery to Participants in Incentive Program

November 19, 2025

Ascelia Pharma Announces FDA Acceptance of Orviglance New Drug Application for Review

November 15, 2025

Ascelia Pharma Files New Patent Application for Orviglance

November 10, 2025

Ascelia Pharma Announces Management Changes to Support Future Growth

November 3, 2025

Ascelia Pharma Submits Orviglance New Drug Application to the U.S. Food and Drug Administration

September 3, 2025

Ascelia Pharma Updates Timeline for Submission of the Orviglance NDA

August 15, 2025

Bulletin from the Annual General Meeting in Ascelia Pharma AB on 7 May 2025

May 7, 2025

Calls in 2025

Decks in 2025